Nuclear Medicine and Biology
Volume 37, Issue 2 , Pages 133-141 , February 2010

An improved radiosynthesis of [18F]AV-133: a PET imaging agent for vesicular monoamine transporter 2

  • Lin Zhu

      Affiliations

    • Key Laboratory of Radiopharmaceuticals, Beijing Normal University, Ministry of Education, Beijing 100875, P.R. China
    • Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • ,
  • Yajing Liu

      Affiliations

    • Key Laboratory of Radiopharmaceuticals, Beijing Normal University, Ministry of Education, Beijing 100875, P.R. China
    • Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • ,
  • Karl Plössl

      Affiliations

    • Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • ,
  • Brian Lieberman

      Affiliations

    • Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • ,
  • Jingying Liu

      Affiliations

    • Key Laboratory of Radiopharmaceuticals, Beijing Normal University, Ministry of Education, Beijing 100875, P.R. China
    • Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • ,
  • Hank F. Kung

      Affiliations

    • Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • Department of Pharmacology, University of Pennsylvania, Philadelphia, PA 19104, USA
    • Corresponding Author InformationCorresponding author. Department of Radiology, University of Pennsylvania, Philadelphia, PA 19104, USA. Tel.: +1 215 662 3989; fax: +1 215 349 5035.

Received 2 October 2009 ,Revised 23 October 2009 ,Accepted 26 October 2009.

References 

  1. Weihe E, Schafer MK, Erickson JD, Eiden LE. Localization of vesicular monoamine transporter isoforms (VMAT1 and VMAT2) to endocrine cells and neurons in rat. J Mol Neurosci. 1994;5:149–164
  2. Adam Y, Edwards RH, Schuldiner S. Expression and function of the rat vesicular monoamine transporter 2. Am J Physiol Cell Physiol. 2008;294:C1004–C1011
  3. Frey KA, Koeppe RA, Kilbourn MR. Imaging the vesicular monoamine transporter. Adv Neurol. 2001;86:237–247
  4. Ding YS, Fowler JS, Volkow ND, Dewey SL, Wang GJ, Logan J, et al. Chiral drugs: comparison of the pharmacokinetics of [11C]d-threo and l-threo-methylphenidate in the human and baboon brain. Psychopharmacology (Berl). 1997;131:71–78
  5. Stehouwer JS, Jarkas N, Zeng F, Voll RJ, Williams L, Owens MJ, et al. Synthesis, radiosynthesis, and biological evaluation of carbon-11 labeled 2beta-carbomethoxy-3beta-(3′-((Z)-2-haloethenyl)phenyl)nortropanes: candidate radioligands for in vivo imaging of the serotonin transporter with positron emission tomography. J Med Chem. 2006;49:6760–6767
  6. Riss PJ, Hooker JM, Alexoff D, Kim SW, Fowler JS, Roesch F. [11C]PR04.MZ, a promising DAT ligand for low concentration imaging: synthesis, efficient 11C-O-methylation and initial small animal PET studies. Bioorg Med Chem Lett. 2009;19:4343–4345
  7. Brooks DJ, Piccini P. Imaging in Parkinson's disease: the role of monoamines in behavior. Biol Psychiatry. 2006;59:908–918
  8. Ettlinger DE, Haeusler D, Wadsak W, Girschele F, Sindelar KM, Mien LK, et al. Metabolism and autoradiographic evaluation of [18F]FE@CIT: a comparison with [123I]beta-CIT and [123I]FP-CIT. Nucl Med Biol. 2008;35:475–479
  9. Goodman MM, Kilts CD, Keil R, Shi B, Martarello L, Xing D, et al. 8F-Labeled FECNT: a selective radioligand for PET imaging of brain dopamine transporters. Nucl Med Biol. 2000;27:1–12
  10. Koivula T, Marjamaki P, Haaparanta M, Fagerholm V, Gronroos T, Lipponen T, et al. Ex vivo evaluation of N-(3-[18F]fluoropropyl)-2beta-carbomethoxy-3beta-(4-fluorophenyl)nortropane in rats. Nucl Med Biol. 2008;35:177–183
  11. Seibyl JP. Single-photon emission computed tomography and positron emission tomography evaluations of patients with central motor disorders. Semin Nucl Med. 2008;38:274–286
  12. Kung HF, Kung MP, Wey SP, Lin KJ, Yen TC. Clinical acceptance of a molecular imaging agent: a long march with [(99m)Tc]TRODAT. Nucl Med Biol. 2007;34:787–789
  13. Pletscher A, Brossi A, Gey KF. Benzoquinoline derivatives: a new class of monoamine decreasing drugs with psychotropic action. Int Rev Neurobiol. 1962;275–305
  14. Saner A, Pletscher A. A benzo[a]quinolizine derivative with a neuroleptic-like action on cerebral monoamine turnover. J Pharmacol Exp Ther. 1977;203:556–563
  15. DaSilva JN, Kilbourn MR. In vivo binding of [11C]tetrabenazine to vesicular monoamine transporters in mouse brain. Life Sci. 1992;51:593–600
  16. Vander Borght TM, Kilbourn MR, Koeppe RA, DaSilva JN, Carey JE, Kuhl DE, et al. In vivo imaging of the brain vesicular monoamine transporter. J Nucl Med. 1995;36:2252–2260
  17. Frey KA, Koeppe RA, Kilbourn MR, Vander Borght TM, Albin RL, Gilman S, et al. Presynaptic monoaminergic vesicles in Parkinson's disease and normal aging. Ann Neurol. 1996;40:873–884
  18. Kilbourn MR. In vivo radiotracers for vesicular neurotransmitter transporters. Nucl Med Biol. 1997;24:615–619
  19. Bohnen NI, Albin RL, Koeppe RA, Wernette KA, Kilbourn MR, Minoshima S, et al. Positron emission tomography of monoaminergic vesicular binding in aging and Parkinson disease. J Cereb Blood Flow Metab. 2006;26:1198–1212
  20. Albin RL, Koeppe RA, Wernette K, Zhuang W, Nichols T, Kilbourn MR, et al. Striatal [11C]dihydrotetrabenazine and [11C]methylphenidate binding in Tourette syndrome. Neurology. 2009;72:1390–1396
  21. Kung MP, Hou C, Goswami R, Ponde DE, Kilbourn MR, Kung HF. Characterization of optically resolved 9-fluoropropyl-dihydrotetrabenazine as a potential PET imaging agent targeting vesicular monoamine transporters. Nucl Med Biol. 2007;34:239–246
  22. Kilbourn MR, Hockley B, Lee L, Hou C, Goswami R, Ponde DE, et al. Pharmacokinetics of [(18)F]fluoroalkyl derivatives of dihydrotetrabenazine in rat and monkey brain. Nucl Med Biol. 2007;34:233–237
  23. Qu W, Kung MP, Hou C, Oya S, Kung HF. Quick assembly of 1,4-diphenyltriazoles as probes targeting beta-amyloid aggregates in Alzheimer's disease. J Med Chem. 2007;50:3380–3387
  24. Goswami R, Ponde DE, Kung MP, Hou C, Kilbourn MR, Kung HF. Fluoroalkyl derivatives of dihydrotetrabenazine as positron emission tomography imaging agents targeting vesicular monoamine transporters. Nucl Med Biol. 2006;33:685–694
  25. Miller PW, Long NJ, Vilar R, Gee AD. Synthesis of 11C, 18F, 15O, and 13N radiolabels for positron emission tomography. Angew Chem Int Ed. 2008;47:8998–9033
  26. Le Bars D. Fluorine-18 and medical imaging: radiopharmaceuticals for positron emission tomography. J Fluorine Chem. 2006;127:1488–1493
  27. Cai L, Lu S, Pike VW. Chemistry with [18F]fluoride ion. Eur J Org Chem. 2008;2853–2873

PII: S0969-8051(09)00253-4

doi: 10.1016/j.nucmedbio.2009.10.005

Nuclear Medicine and Biology
Volume 37, Issue 2 , Pages 133-141 , February 2010

Article Tools

* Image Usage & Resolution